Fulcrum Therapeutics Inc (FULC)
EBITDA Growth
-5.92%
TTM · Period ending:
FULC EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-5.92%period ending
Latest reported-5.92%period ending
FULC TTM EBITDA YoY % (-154.40% → -5.92%)
Year-over-year change
High-resolution chart · PNG
FULC ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -5.9223% | |
| -18,129.5122% | |
| -673.6604% | |
| -297.2077% | |
| -298.8386% | |
| 99.5788% | |
| 90.0182% | |
| 82.1549% | |
| 81.3101% | |
| 10.1241% | |
| 13.0812% | |
| 6.2834% | |
| 3.5559% | |
| -24.0221% | |
| -39.692% | |
| -44.5947% | |
| -43.2639% | |
| -29.5379% | |
| -13.2078% | |
| -7.0594% | |
| -8.0612% | |
| -6.4487% | |
| 15.3612% | |
| 9.5456% | |
| 2.0157% | |
| -2.5769% | |
| -154.3993% |